Breuer K et al. |
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. |
2005 |
Am J Clin Dermatol |
pmid:15799678
|
Kalavala M and Dohil MA |
Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. |
2011 |
Am J Clin Dermatol |
pmid:21067248
|
Yang LP and Curran MP |
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. |
2010 |
Am J Clin Dermatol |
pmid:20509720
|
Cheer SM and Plosker GL |
Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. |
2001 |
Am J Clin Dermatol |
pmid:11770393
|
Ozden MG et al. |
Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study. |
2010 |
Am J Clin Dermatol |
pmid:20000875
|
Patel TS et al. |
Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians. |
2007 |
Am J Clin Dermatol |
pmid:17645374
|
Frankel HC and Qureshi AA |
Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. |
2012 |
Am J Clin Dermatol |
pmid:22263704
|
Iskedjian M et al. |
Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. |
2004 |
Am J Clin Dermatol |
pmid:15301573
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Siegfried EC et al. |
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. |
2013 |
Am J Clin Dermatol |
pmid:23703374
|
Tjioe M et al. |
Topical macrolide immunomodulators: a role in the treatment of vitiligo? |
2006 |
Am J Clin Dermatol |
pmid:16489839
|
Valdivielso-Ramos M et al. |
Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. |
2008 |
Am J Clin Dermatol |
pmid:18429647
|
Cook BA and Warshaw EM |
Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. |
2009 |
Am J Clin Dermatol |
pmid:19222250
|
Ingram JR et al. |
Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. |
2009 |
Am J Clin Dermatol |
pmid:19489656
|
Reitamo S et al. |
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113647
|
Wellington K and Jarvis B |
Spotlight on topical pimecrolimus in atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113651
|
Lübbe J et al. |
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice. |
2006 |
Am J Clin Dermatol |
pmid:16605292
|
Ellis CN et al. |
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age. |
2006 |
Am J Clin Dermatol |
pmid:16605293
|
Wollina U |
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. |
2007 |
Am J Clin Dermatol |
pmid:17492844
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|
|
Roche, FDA announce new drug-interaction warnings for mibefradil. |
1998 |
Am J Health Syst Pharm |
pmid:9492249
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Greanya ED et al. |
Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. |
2012 |
Am J Health Syst Pharm |
pmid:22215359
|
Heavner MS et al. |
Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. |
2013 |
Am J Health Syst Pharm |
pmid:23943182
|
Curtin BF et al. |
Unusually late-onset mycophenolate mofetil-related colitis. |
2014 |
Am J Health Syst Pharm |
pmid:25320135
|
Bonhomme-Faivre L et al. |
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. |
2009 |
Am J Health Syst Pharm |
pmid:19729569
|
Lee JH et al. |
Stability of tacrolimus solutions in polyolefin containers. |
2016 |
Am J Health Syst Pharm |
pmid:26796907
|
|
Tacrolimus. |
2001 |
Am J Health Syst Pharm |
pmid:11794952
|
Lee B et al. |
Appropriate timing of tacrolimus concentration measurements in the emergency department. |
2016 |
Am J Health Syst Pharm |
pmid:27543574
|
Jacobson PA et al. |
Stability of tacrolimus in an extemporaneously compounded oral liquid. |
1997 |
Am J Health Syst Pharm |
pmid:9117806
|
Utecht KN et al. |
Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. |
2006 |
Am J Health Syst Pharm |
pmid:17106006
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Johnson CE et al. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. |
1999 |
Am J Health Syst Pharm |
pmid:10030533
|
Pennington CA and Park JM |
Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. |
2015 |
Am J Health Syst Pharm |
pmid:25631834
|
Tsapepas DS et al. |
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. |
2011 |
Am J Health Syst Pharm |
pmid:21200061
|
Myers AL et al. |
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags. |
2016 |
Am J Health Syst Pharm |
pmid:27919876
|
Grouzmann E et al. |
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. |
2008 |
Am J Health Syst Pharm |
pmid:18216007
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Min DI et al. |
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. |
1992 |
Am J Hosp Pharm |
pmid:1282779
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Przepiorka D et al. |
Blood tacrolimus concentration unchanged by plasmapheresis. |
1994 |
Am J Hosp Pharm |
pmid:7524318
|
Matsunami H et al. |
New technique for measuring tacrolimus concentrations in blood. |
1994 |
Am J Hosp Pharm |
pmid:7510929
|
Pezze JL and Whiteman K |
Transplantation's newest weapon FK 506. |
1991 |
Am J Nurs |
pmid:1716857
|
Yang GS et al. |
Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. |
2000 |
Am J Otol |
pmid:10912694
|
Tulaci KG et al. |
The effect of tacrolimus on facial nerve injury: Histopathological findings in a rabbit model. |
|
Am J Otolaryngol |
pmid:27465503
|
Knott PD et al. |
Induction with T-cell receptor antibody leads to long-term laryngeal allograft function. |
2008 Nov-Dec |
Am J Otolaryngol |
pmid:19144301
|
Laifer SA et al. |
Pregnancy after cardiac transplantation. |
1994 |
Am J Perinatol |
pmid:7519426
|
Lee J et al. |
Inpatient rehabilitation challenges in a quadrimembral amputee after bilateral hand transplantation. |
2011 |
Am J Phys Med Rehabil |
pmid:21765280
|
Reams BD and Palmer SM |
Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. |
2002 |
Am J Respir Med |
pmid:14720063
|
Moon BJ et al. |
Effect of chronic rhinosinusitis on liver transplant patients. |
2009 Sep-Oct |
Am J Rhinol Allergy |
pmid:19807981
|
Shin JH et al. |
The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis. |
2012 Mar-Apr |
Am J Rhinol Allergy |
pmid:22487280
|
Vearrier D et al. |
Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation. |
2011 |
Am J Ther |
pmid:20535006
|
Yang A and Wang B |
Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival. |
|
Am J Ther |
pmid:23921809
|
Pariser D |
Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. |
2009 May-Jun |
Am J Ther |
pmid:19262357
|
Sathyan S et al. |
Prevention of recurrent episodes of rhabdomyolysis with tacrolimus in a transplant recipient with myopathy. |
|
Am J Ther |
pmid:23429166
|
Liu JY et al. |
Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation. |
|
Am J Ther |
pmid:25299636
|
Haroon N et al. |
Tacrolimus Toxicity With Minimal Clinical Manifestations: A Case Report and Literature Review. |
|
Am J Ther |
pmid:25730156
|
Nunokawa T et al. |
Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report. |
|
Am J Ther |
pmid:22836123
|
Liu JY et al. |
Sirolimus Versus Tacrolimus as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation. |
|
Am J Ther |
pmid:25569597
|
Cohen SM |
Current immunosuppression in liver transplantation. |
2002 Mar-Apr |
Am J Ther |
pmid:11897926
|
Yousuf Bhat Z et al. |
Colchicine-Induced Myopathy in a Tacrolimus-Treated Renal Transplant Recipient: Case Report and Literature Review. |
|
Am J Ther |
pmid:24732905
|
Azizian M et al. |
Augmentation of ischemia/reperfusion injury to endothelial cells by cyclosporin A. |
2004 |
Am Surg |
pmid:15156953
|
Henderson CN et al. |
Continuous Abdominal Irrigation for Treatment of Tertiary Peritonitis in the Immunosuppressed Patient after Solid Organ Transplant: A Novel Approach. |
2017 |
Am Surg |
pmid:28424115
|
Rojas-GarcÃa P et al. |
Breast fibroadenomas associated with immunosuppressive drugs. |
2010 |
Am Surg |
pmid:21418766
|
Kodama M et al. |
FK506 therapy of experimental autoimmune myocarditis after onset of the disease. |
1993 |
Am. Heart J. |
pmid:7504393
|
Chieffo A et al. |
Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. |
2009 |
Am. J. Cardiol. |
pmid:19962471
|
Chang RK et al. |
Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. |
1998 |
Am. J. Cardiol. |
pmid:9604971
|
Klauss V et al. |
Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. |
2000 |
Am. J. Cardiol. |
pmid:10955391
|
Herzberg GZ et al. |
Usefulness of tacrolimus versus cyclosporine after pediatric heart transplantation. |
1998 |
Am. J. Cardiol. |
pmid:9723652
|
Hisamura F et al. |
Synergistic effect of green tea polyphenols on their protection against FK506-induced cytotoxicity in renal cells. |
2008 |
Am. J. Chin. Med. |
pmid:18543393
|
Chung SY et al. |
Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain. |
2006 |
Am. J. Chin. Med. |
pmid:17080546
|
Stickle DF et al. |
Effects of sterilizing gamma irradiation on bloodspot newborn screening tests and whole blood cyclosporine and tacrolimus measurements. |
2003 |
Am. J. Clin. Pathol. |
pmid:12580001
|
Wang E et al. |
Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. |
2011 |
Am. J. Clin. Pathol. |
pmid:21228370
|
Burke MT et al. |
Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients. |
2015 |
Am. J. Clin. Pathol. |
pmid:25780003
|
Lower DR et al. |
Comparison of CEDIA FK506 assay with HPLC/MS/MS in a large cohort of pediatric patients. |
2013 |
Am. J. Clin. Pathol. |
pmid:23690122
|
Rudi J et al. |
Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. |
1997 |
Am. J. Gastroenterol. |
pmid:9317070
|
Van Thiel DH et al. |
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7532912
|
Baumgart DC et al. |
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. |
2006 |
Am. J. Gastroenterol. |
pmid:16573777
|
Sandborn WJ |
Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. |
1997 |
Am. J. Gastroenterol. |
pmid:9149205
|
Van Thiel DH et al. |
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7537444
|
Fellermann K et al. |
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). |
1998 |
Am. J. Gastroenterol. |
pmid:9772045
|
Nara M et al. |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3. |
2010 |
Am. J. Hematol. |
pmid:20568249
|
Lekakis LJ et al. |
BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. |
2009 |
Am. J. Hematol. |
pmid:19208419
|
Hammerstrom AE et al. |
Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. |
2013 |
Am. J. Hematol. |
pmid:23460378
|
Abdel-Azim H et al. |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. |
2015 |
Am. J. Hematol. |
pmid:26242764
|
Uehara T et al. |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. |
2004 |
Am. J. Hematol. |
pmid:15282671
|
Nakamae H et al. |
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. |
2006 |
Am. J. Hematol. |
pmid:16755559
|
Bolaños-Meade J et al. |
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. |
2005 |
Am. J. Hematol. |
pmid:15929116
|
Ninan MJ and Datta YH |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma. |
2010 |
Am. J. Hematol. |
pmid:20578201
|
Mach-Pascual S et al. |
Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. |
1996 |
Am. J. Hematol. |
pmid:8701950
|
Uehara T et al. |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. |
2002 |
Am. J. Hematol. |
pmid:12221672
|
Cohen DL et al. |
Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients. |
2004 |
Am. J. Hypertens. |
pmid:15001192
|
Zhang W and Victor RG |
Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. |
2000 |
Am. J. Hypertens. |
pmid:10981550
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Kooman JP et al. |
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. |
2001 |
Am. J. Kidney Dis. |
pmid:11382685
|
Birdwell KA et al. |
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. |
2009 |
Am. J. Kidney Dis. |
pmid:19185404
|
First MR |
Renal transplantation for the nephrologist: new immunosuppressive drugs. |
1992 |
Am. J. Kidney Dis. |
pmid:1371201
|
Israni A et al. |
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877596
|
Tsinalis D et al. |
Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. |
2002 |
Am. J. Kidney Dis. |
pmid:12200824
|